US Patent Issued to Washington University, Senseion Therapeutics on July 21 for "Suppression of inflammasome activation" (Missouri Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,717, issued on July 21, was assigned to Washington University (St. Louis) and Senseion Therapeutics Inc. (St. Louis). "Suppression of infla... Read More

US Patent Issued to LUCTA on July 21 for "Feed additive" (Spanish Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,718, issued on July 21, was assigned to LUCTA S.A. (Madrid). "Feed additive" was invented by Jose Javier Pastor Porras (Madrid), Maria Gema... Read More

US Patent Issued to UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION on July 21 for "Treatment of breast cancer with selective androgen receptor modulators and cyclin-dependent kinase 4/6 inhibitors" (American, South Korean Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,719, issued on July 21, was assigned to UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, Tenn.). "Treatment of breast cancer with se... Read More

US Patent Issued to Somerset Therapeutics on July 21 for "Compositions for the effective treatment of vitamin C deficiency-related diseases and other conditions" (New Jersey Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,720, issued on July 21, was assigned to Somerset Therapeutics LLC (Somerset, N.J.). "Compositions for the effective treatment of vitamin C ... Read More

US Patent Issued to GH Research Ireland on July 21 for "Aerosol comprising 5-methoxy-N,N-dimethyltryptamine" (German Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,721, issued on July 21, was assigned to GH Research Ireland Ltd. (Dublin). "Aerosol comprising 5-methoxy-N,N-dimethyltryptamine" was invent... Read More

US Patent Issued to Atai Therapeutics on July 21 for "Compositions of matter and pharmaceutical compositions" (Florida Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,722, issued on July 21, was assigned to Atai Therapeutics Inc. (New York). "Compositions of matter and pharmaceutical compositions" was inv... Read More

US Patent Issued to Azurity Pharmaceuticals on July 21 for "Oral pharmaceutical composition comprising Zonisamide and process of preparation thereof" (Indian Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,723, issued on July 21, was assigned to Azurity Pharmaceuticals Inc. (Woburn, Mass.). "Oral pharmaceutical composition comprising Zonisamid... Read More

US Patent Issued to ICHILOV TECH on July 21 for "Antidepressant therapy" (Israeli Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,724, issued on July 21, was assigned to ICHILOV TECH LTD. (Tel Aviv, Israel). "Antidepressant therapy" was invented by Einor Ben Assayag (S... Read More

US Patent Issued to PRILENIA NEUROTHERAPEUTICS on July 21 for "Pridopidine for the treatment of mitochondrial-associated diseases and disorders and endoplasmic reticulum (ER) stress" (Israeli, Portuguese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,725, issued on July 21, was assigned to PRILENIA NEUROTHERAPEUTICS LTD. (Yakum, Israel). "Pridopidine for the treatment of mitochondrial-as... Read More

US Patent Issued to Gruenenthal on July 21 for "Sulfoximines as inhibitors of NaV1.8" (German Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,726, issued on July 21, was assigned to Gruenenthal GmbH (Germany). "Sulfoximines as inhibitors of NaV1.8" was invented by Marcel Muelbaier... Read More

• ««
• «
• 3077
• 3078
• 3079
• 3080
• 3081
• 3082
• 3083
• 3084
• 3085
• 3086
• »
• »»